133 related articles for article (PubMed ID: 21925913)
21. Deterioration of quality of life of high-risk breast cancer patients treated with high-dose chemotherapy: the PEGASE 01 Quality of Life Study.
Marino P; Roché H; Biron P; Janvier M; Spaeth D; Fabbro M; Linassier C; Delozier T; Martin AL; Santin G; Moatti JP;
Value Health; 2008; 11(4):709-18. PubMed ID: 18194401
[TBL] [Abstract][Full Text] [Related]
22. Life quality of women with breast cancer after mastectomy or breast conserving therapy treated with adjuvant chemotherapy.
Kamińska M; Ciszewski T; Kukiełka-Budny B; Kubiatowski T; Baczewska B; Makara-Studzińska M; Starosławska E; Bojar I
Ann Agric Environ Med; 2015; 22(4):724-30. PubMed ID: 26706986
[TBL] [Abstract][Full Text] [Related]
23. Quality of life and adjuvant tamoxifen treatment in breast cancer patients.
Boehm DU; Lebrecht A; Eckhardt T; Albrich S; Schmidt M; Siggelkow W; Kandelhardt E; Koelbl H
Eur J Cancer Care (Engl); 2009 Sep; 18(5):500-6. PubMed ID: 19490009
[TBL] [Abstract][Full Text] [Related]
24. Longitudinal impact of yoga on chemotherapy-related cognitive impairment and quality of life in women with early stage breast cancer: a case series.
Galantino ML; Greene L; Daniels L; Dooley B; Muscatello L; O'Donnell L
Explore (NY); 2012; 8(2):127-35. PubMed ID: 22385567
[TBL] [Abstract][Full Text] [Related]
25. Health related quality of life of women in TEACH, a randomised placebo controlled adjuvant trial of lapatinib in early stage Human Epidermal Growth Factor Receptor (HER2) overexpressing breast cancer.
Boyle FM; Smith IE; O'Shaughnessy J; Ejlertsen B; Buzdar AU; Fumoleau P; Gradishar W; Martin M; Moy B; Piccart-Gebhart M; Pritchard KI; Lindquist D; Amonkar M; Huang Y; Rappold E; Williams LS; Wang-Silvanto J; Kaneko T; Finkelstein DM; Goss PE;
Eur J Cancer; 2015 Apr; 51(6):685-96. PubMed ID: 25752740
[TBL] [Abstract][Full Text] [Related]
26. Effect of cosmetic outcome on quality of life after breast cancer surgery.
Kim MK; Kim T; Moon HG; Jin US; Kim K; Kim J; Lee JW; Kim J; Lee E; Yoo TK; Noh DY; Minn KW; Han W
Eur J Surg Oncol; 2015 Mar; 41(3):426-32. PubMed ID: 25578249
[TBL] [Abstract][Full Text] [Related]
27. The preference to receive chemotherapy and cancer-related outcomes in older adults with breast cancer CALGB 49907 (Alliance).
Gajra A; McCall L; Muss HB; Cohen HJ; Jatoi A; Ballman KV; Partridge AH; Sutton L; Parker BA; Magrinat G; Klepin HD; Lafky JM; Hurria A
J Geriatr Oncol; 2018 May; 9(3):221-227. PubMed ID: 29602735
[TBL] [Abstract][Full Text] [Related]
28. Pretreatment quality of life, performance status and their relation to treatment discontinuation and treatment changes in high-risk breast cancer patients receiving chemotherapy: results from the prospective randomized ADEBAR trial.
Eichler M; Singer S; Janni W; Harbeck N; Rack B; Augustin D; Wischnik A; Kiechle M; Ettl J; Scholz C; Fink V; Schwentner L
Breast Cancer; 2017 Mar; 24(2):319-325. PubMed ID: 27262301
[TBL] [Abstract][Full Text] [Related]
29. Weight gain and quality of life in women treated with adjuvant chemotherapy for early-stage breast cancer.
McInnes JA; Knobf MT
Oncol Nurs Forum; 2001 May; 28(4):675-84. PubMed ID: 11383182
[TBL] [Abstract][Full Text] [Related]
30. A randomized double-blind placebo-controlled cross-over trial of the impact on quality of life of continuing dexamethasone beyond 24 h following adjuvant chemotherapy for breast cancer.
Vardy J; Pond G; Dodd A; Warr D; Seruga B; Clemons M; Bordeleau L; Goodwin P; Tannock IF
Breast Cancer Res Treat; 2012 Nov; 136(1):143-51. PubMed ID: 22956006
[TBL] [Abstract][Full Text] [Related]
31. Chemotherapy versus ovarian ablation as adjuvant therapy for breast cancer: impact on health-related quality of life in a randomized trial.
Groenvold M; Fayers PM; Petersen MA; Mouridsen HT
Breast Cancer Res Treat; 2006 Aug; 98(3):275-84. PubMed ID: 16541325
[TBL] [Abstract][Full Text] [Related]
32. Anxiety and quality of life of women who receive radiation or chemotherapy for breast cancer.
Schreier AM; Williams SA
Oncol Nurs Forum; 2004; 31(1):127-30. PubMed ID: 14722597
[TBL] [Abstract][Full Text] [Related]
33. Personality traits and psychosocial stress: quality of life over 2 years following breast cancer diagnosis and psychological impact factors.
Härtl K; Engel J; Herschbach P; Reinecker H; Sommer H; Friese K
Psychooncology; 2010 Feb; 19(2):160-9. PubMed ID: 19189279
[TBL] [Abstract][Full Text] [Related]
34. Effects of surgical and adjuvant therapies for breast cancer on sexuality, cognitive functions, and body weight.
Biglia N; Moggio G; Peano E; Sgandurra P; Ponzone R; Nappi RE; Sismondi P
J Sex Med; 2010 May; 7(5):1891-900. PubMed ID: 20233281
[TBL] [Abstract][Full Text] [Related]
35. Effects of resistance exercise on fatigue and quality of life in breast cancer patients undergoing adjuvant chemotherapy: A randomized controlled trial.
Schmidt ME; Wiskemann J; Armbrust P; Schneeweiss A; Ulrich CM; Steindorf K
Int J Cancer; 2015 Jul; 137(2):471-80. PubMed ID: 25484317
[TBL] [Abstract][Full Text] [Related]
36. Symptoms of hormonal therapy and social support: Is there a connection? Comparison of symptom severity, symptom interference and social support among breast cancer patients receiving and not receiving adjuvant hormonal treatment.
Ochayon L; Tunin R; Yoselis A; Kadmon I
Eur J Oncol Nurs; 2015 Jun; 19(3):260-7. PubMed ID: 25529935
[TBL] [Abstract][Full Text] [Related]
37. Characteristics and correlates of fatigue after adjuvant chemotherapy for breast cancer.
Broeckel JA; Jacobsen PB; Horton J; Balducci L; Lyman GH
J Clin Oncol; 1998 May; 16(5):1689-96. PubMed ID: 9586880
[TBL] [Abstract][Full Text] [Related]
38. Cognitive functioning during long-term tamoxifen treatment in postmenopausal women with breast cancer.
Boele FW; Schilder CM; de Roode ML; Deijen JB; Schagen SB
Menopause; 2015 Jan; 22(1):17-25. PubMed ID: 24977455
[TBL] [Abstract][Full Text] [Related]
39. The role of health-related quality of life in early discontinuation of chemotherapy for breast cancer.
Richardson LC; Wang W; Hartzema AG; Wagner S
Breast J; 2007; 13(6):581-7. PubMed ID: 17983400
[TBL] [Abstract][Full Text] [Related]
40. Quality of life in women with breast cancer during the first year after random assignment to adjuvant treatment with marrow-supported high-dose chemotherapy with cyclophosphamide, thiotepa, and carboplatin or tailored therapy with Fluorouracil, epirubicin, and cyclophosphamide: Scandinavian Breast Group Study 9401.
Brandberg Y; Michelson H; Nilsson B; Bolund C; Erikstein B; Hietanen P; Kaasa S; Nilsson J; Wiklund T; Wilking N; Bergh J;
J Clin Oncol; 2003 Oct; 21(19):3659-64. PubMed ID: 14512398
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
